| Pharmacologic resistance in colorectal cancer: a review WA Hammond, A Swaika, K Mody Therapeutic advances in medical oncology 8 (1), 57-84, 2016 | 554 | 2016 |
| Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy A Swaika, WA Hammond, RW Joseph Molecular immunology 67 (2), 4-17, 2015 | 299 | 2015 |
| Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma AA Chanan-Khan, A Swaika, A Paulus, SK Kumar, JR Mikhael, ... Blood cancer journal 3 (9), e143-e143, 2013 | 146 | 2013 |
| Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis S Ailawadhi, RD Frank, P Advani, A Swaika, M Temkit, R Menghani, ... Cancer medicine 6 (12), 2876-2885, 2017 | 89 | 2017 |
| Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma A Swaika, JA Crozier, RW Joseph Drug design, development and therapy, 775-787, 2014 | 89 | 2014 |
| Biological effects and clinical significance of lenalidomide‐induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of … AA Chanan‐Khan, K Chitta, N Ersing, A Paulus, A Masood, T Sher, ... British journal of haematology 155 (4), 457-467, 2011 | 81 | 2011 |
| Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines JA Crozier, A Swaika, A Moreno-Aspitia World journal of clinical oncology 5 (3), 529, 2014 | 79 | 2014 |
| Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities S Ailawadhi, RD Frank, M Sharma, R Menghani, M Temkit, S Paulus, ... Cancer 124 (8), 1710-1721, 2018 | 53 | 2018 |
| Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients A Swaika, A Paulus, KC Miller, T Sher, NG Almyroudis, D Ball, M Wood, ... The journal of supportive oncology 10 (4), 155-159, 2012 | 45 | 2012 |
| Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes A Swaika, RD Frank, D Yang, LE Finn, L Jiang, P Advani, ... Cancer medicine 7 (2), 499-507, 2018 | 39 | 2018 |
| Persistent disparities among patients with T-cell non-Hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: a SEER database review JA Crozier, T Sher, D Yang, A Swaika, J Foran, R Ghosh, H Tun, ... Clinical Lymphoma Myeloma and Leukemia 15 (10), 578-585, 2015 | 33 | 2015 |
| Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups S Ailawadhi, A Swaika, P Razavi, D Yang, A Chanan-Khan Blood cancer journal 4 (9), e243-e243, 2014 | 29 | 2014 |
| Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cells KS Chitta, ANH Khan, N Ersing, A Swaika, A Masood, A Paulus, A Qadeer, ... Leukemia & lymphoma 55 (3), 652-661, 2014 | 29 | 2014 |
| Impact of access to NCI‐and NCCN‐designated cancer centers on outcomes for multiple myeloma patients: a SEER registry analysis S Ailawadhi, P Advani, D Yang, R Ghosh, A Swaika, V Roy, J Foran, ... Cancer 122 (4), 618-625, 2016 | 28 | 2016 |
| Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies AJ Shreders, SK Niazi, DO Hodge, NT Chimato, M Kureti, N Kirla, ... Annals of hematology 97, 519-528, 2018 | 27 | 2018 |
| Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod RW Joseph, M Cappel, K Tzou, S Bagaria, C Gilstrap, A Swaika, ... Melanoma research 26 (4), 409-412, 2016 | 27 | 2016 |
| Clinical relapse in a patient with multiple myeloma presenting as an atrial plasmacytoma A Paulus, A Swaika, KC Miller, EJ Spangenthal, R Guo, K VonFricken, ... Journal of Clinical Oncology 29 (3), e47-e49, 2011 | 17 | 2011 |
| Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma MY Kim, R Sposto, A Swaika, H Asano, A Alamgir, A Chanan-Khan, ... Oncology 87 (4), 224-231, 2014 | 12 | 2014 |
| Hairy cell lymphoma: a potentially under-recognized entity WA Hammond, A Swaika, D Menke, HW Tun Rare Tumors 9 (1), 1-3, 2017 | 11 | 2017 |
| Remission induction with lenalidomide in a patient with relapsed diffuse large B cell lymphoma of the leg type A Swaika, DM Menke, MK Jain, T Sher Annals of Hematology 94, 895-896, 2015 | 9 | 2015 |
